For U.S. Full Product Information including Boxed WARNINGS about allergic reactions and heart attack click here.

ERBITUX is a registered trademark of ImClone LLC. ImClone LLC has granted to Merck KGaA, Darmstadt, Germany, exclusive rights to develop and commercialize ERBITUX outside of the United States and Canada and co-exclusive rights to develop ERBITUX in Japan.

©2011, ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, New York, NY 10014 and Bristol-Myers Squibb Company, Princeton, NJ, 08543, U.S.A. All rights reserved.

ERBITUX^® is a registered trademark of ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.